We wanted to visualize whether the decrease in the transcript levels of pro-proliferative markers upon MEX3B RNAi is also reflected in the distribution of proliferation-primed and differentiation-primed cells within the NPC population, and if this distribution was influenced by bFGF. The gene discussed is FGF2; the disease is nasopharyngeal carcinoma.